The risk for hydroxychloroquine retinopathy increases with higher dosing per actual and ideal body weight, and with longer duration of use, according to data presented at ACR Convergence 2021.
When hydroxychloroquine use causes mild retinopathy, people have no symptoms, and specialized screening tests, such as OCT, are needed to detect retinal damage, April M. Jorge, MD, of Massachusetts General Hospital in Boston, said during a virtual press conference, where she presented data from a prospective analysis of risk factors for hydroxychloroquine retinopathy and its subtypes.
“This